NEW YORK – Single-cell technology company Scale Biosciences said Wednesday that it has launched a so-called "100 Million Cell Challenge" grant program in collaboration with Ultima Genomics and Nvidia.
Researchers worldwide are invited to submit proposals for large-scale single-cell sequencing projects that aim to analyze a minimum of 1 million cells with no upper limit across diverse biological systems and research areas.
Scale Bio said the initiative will provide "substantially subsidized costs" for library preparation and sequencing services. Selected projects will also benefit from early access to Scale Bio’s QuantumScale, the company’s newest single-cell RNA-sequencing technology that promises to handle up to 2 million cells per run.
Additionally, participants will receive high-throughput sequencing and accelerated computing services through Scale Bio’s partnership with Ultima and Nvidia.
Researchers interested in participating can submit their project proposals until Oct. 15, and projects will be evaluated on a rolling basis, Scale Bio said.
"By bringing together researchers from various disciplines and providing them with advanced technology from Scale Bio and our collaborators, we aim to catalyze new discoveries that will shape the future of precision medicine, further our understanding of complex biological systems, and fuel the explosion of generative AI that is being leveraged in biology," Scale Bio President and CEO Giovanna Prout said in a statement.